nodes	percent_of_prediction	percent_of_DWPC	metapath
Clidinium—Diphenylpyraline—SLC6A3—Parkinson's disease	0.0174	0.187	CrCbGaD
Clidinium—Benzatropine—SLC6A3—Parkinson's disease	0.0133	0.144	CrCbGaD
Clidinium—Trospium—CYP2D6—Parkinson's disease	0.0109	0.117	CrCbGaD
Clidinium—Darifenacin—CYP2D6—Parkinson's disease	0.00789	0.0851	CrCbGaD
Clidinium—Fexofenadine—CYP2D6—Parkinson's disease	0.00768	0.0828	CrCbGaD
Clidinium—Benzatropine—CYP2D6—Parkinson's disease	0.00701	0.0756	CrCbGaD
Clidinium—Fexofenadine—ABCB1—Parkinson's disease	0.00548	0.0591	CrCbGaD
Clidinium—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.00513	0.0553	CrCbGaD
Clidinium—Loperamide—CYP2D6—Parkinson's disease	0.00489	0.0527	CrCbGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00376	0.00414	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00375	0.00413	CbGpPWpGaD
Clidinium—CHRM3—Regulation of insulin secretion—INS—Parkinson's disease	0.00371	0.00409	CbGpPWpGaD
Clidinium—Fentanyl—ABCB1—Parkinson's disease	0.00362	0.0391	CrCbGaD
Clidinium—CHRM1—Circadian rythm related genes—DRD1—Parkinson's disease	0.00355	0.00391	CbGpPWpGaD
Clidinium—Loperamide—ABCB1—Parkinson's disease	0.00349	0.0376	CrCbGaD
Clidinium—Methadone—CYP2D6—Parkinson's disease	0.00348	0.0375	CrCbGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00347	0.00382	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00346	0.00381	CbGpPWpGaD
Clidinium—CHRM1—Circadian rythm related genes—DRD3—Parkinson's disease	0.00344	0.00379	CbGpPWpGaD
Clidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00343	0.00378	CbGpPWpGaD
Clidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00342	0.00377	CbGpPWpGaD
Clidinium—CHRM1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.0034	0.00375	CbGpPWpGaD
Clidinium—CHRM3—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00339	0.00374	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.0033	0.00364	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—GRM4—Parkinson's disease	0.00329	0.00363	CbGpPWpGaD
Clidinium—CHRM1—Circadian rythm related genes—TH—Parkinson's disease	0.00316	0.00349	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—PENK—Parkinson's disease	0.00313	0.00345	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—PENK—Parkinson's disease	0.00312	0.00344	CbGpPWpGaD
Clidinium—CHRM1—Circadian rythm related genes—HTR7—Parkinson's disease	0.00311	0.00343	CbGpPWpGaD
Clidinium—CHRM1—Circadian rythm related genes—DRD2—Parkinson's disease	0.00311	0.00343	CbGpPWpGaD
Clidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00304	0.00335	CbGpPWpGaD
Clidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00303	0.00334	CbGpPWpGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00301	0.00332	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.003	0.00331	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00297	0.00327	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00296	0.00326	CbGpPWpGaD
Clidinium—CHRM3—Integration of energy metabolism—INS—Parkinson's disease	0.00292	0.00322	CbGpPWpGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00291	0.0032	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0029	0.00319	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.00286	0.00315	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—PDYN—Parkinson's disease	0.00285	0.00314	CbGpPWpGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00281	0.0031	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00281	0.00309	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00274	0.00303	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00274	0.00302	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00266	0.00293	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—GRM5—Parkinson's disease	0.00265	0.00292	CbGpPWpGaD
Clidinium—CHRM1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00264	0.00291	CbGpPWpGaD
Clidinium—CHRM3—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00263	0.0029	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00258	0.00284	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00257	0.00283	CbGpPWpGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00255	0.00281	CbGpPWpGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00255	0.00281	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00254	0.0028	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00254	0.0028	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00254	0.0028	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00253	0.00279	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00249	0.00275	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00249	0.00275	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00249	0.00274	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—DGKQ—Parkinson's disease	0.00248	0.00274	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—GPR37—Parkinson's disease	0.00248	0.00274	CbGpPWpGaD
Clidinium—Methadone—ABCB1—Parkinson's disease	0.00248	0.0268	CrCbGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00248	0.00274	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00241	0.00266	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0024	0.00265	CbGpPWpGaD
Clidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00236	0.0026	CbGpPWpGaD
Clidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00235	0.00259	CbGpPWpGaD
Clidinium—CHRM1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00231	0.00254	CbGpPWpGaD
Clidinium—CHRM3—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.0023	0.00253	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00228	0.00251	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00227	0.0025	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00226	0.00249	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00226	0.00249	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00218	0.0024	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00218	0.0024	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00217	0.0024	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00217	0.0024	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00208	0.00229	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—GRK5—Parkinson's disease	0.00207	0.00229	CbGpPWpGaD
Clidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00206	0.00227	CbGpPWpGaD
Clidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00206	0.00227	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—MCCC1—Parkinson's disease	0.00197	0.00217	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—ND3—Parkinson's disease	0.00197	0.00217	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00196	0.00216	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—HTR1A—Parkinson's disease	0.00196	0.00216	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00193	0.00213	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—TAC1—Parkinson's disease	0.00193	0.00212	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.0019	0.00209	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—DRD1—Parkinson's disease	0.00189	0.00208	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00189	0.00208	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—GRK5—Parkinson's disease	0.00188	0.00208	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00187	0.00206	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—GRM4—Parkinson's disease	0.00186	0.00205	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—TALDO1—Parkinson's disease	0.00185	0.00204	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—OMD—Parkinson's disease	0.00185	0.00204	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00184	0.00202	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—DRD3—Parkinson's disease	0.00183	0.00202	CbGpPWpGaD
Clidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00178	0.00196	CbGpPWpGaD
Clidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00178	0.00196	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00178	0.00196	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—VPS35—Parkinson's disease	0.00177	0.00195	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00177	0.00195	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—PENK—Parkinson's disease	0.00176	0.00194	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—NDUFB11—Parkinson's disease	0.00176	0.00193	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00175	0.00192	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00174	0.00192	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00169	0.00187	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—GRM4—Parkinson's disease	0.00169	0.00186	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—GCH1—Parkinson's disease	0.00167	0.00185	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00166	0.00183	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00166	0.00183	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—DRD2—Parkinson's disease	0.00166	0.00182	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—HTR7—Parkinson's disease	0.00166	0.00182	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00162	0.00178	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—PDYN—Parkinson's disease	0.00161	0.00178	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.00161	0.00177	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—PENK—Parkinson's disease	0.0016	0.00176	CbGpPWpGaD
Clidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00153	0.00168	CbGpPWpGaD
Clidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00152	0.00168	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0015	0.00166	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.0015	0.00165	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—FBP1—Parkinson's disease	0.00149	0.00164	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—DBH—Parkinson's disease	0.00149	0.00164	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—GBA—Parkinson's disease	0.00149	0.00164	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00147	0.00162	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00147	0.00162	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00147	0.00162	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.00147	0.00162	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.00147	0.00162	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.00146	0.00161	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00137	0.00151	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	0.00136	0.0015	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00135	0.00148	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00134	0.00148	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.00133	0.00147	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.00133	0.00146	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00128	0.00141	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00127	0.0014	CbGpPWpGaD
Clidinium—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.00118	0.0013	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.00118	0.0013	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.00117	0.00129	CbGpPWpGaD
Clidinium—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00116	0.00128	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00116	0.00128	CbGpPWpGaD
Clidinium—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.00116	0.00128	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00116	0.00128	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00112	0.00123	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.00111	0.00123	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00111	0.00122	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00111	0.00122	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—DDC—Parkinson's disease	0.0011	0.00121	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00109	0.0012	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.00109	0.0012	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00107	0.00118	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.00107	0.00118	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00104	0.00114	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.00103	0.00114	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.00103	0.00114	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00101	0.00111	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.001	0.00111	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.001	0.0011	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.000998	0.0011	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000992	0.00109	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000989	0.00109	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000973	0.00107	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.00097	0.00107	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000969	0.00107	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000966	0.00106	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000949	0.00105	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000949	0.00105	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000946	0.00104	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000946	0.00104	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000942	0.00104	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000939	0.00104	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000938	0.00103	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000938	0.00103	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000935	0.00103	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000935	0.00103	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000931	0.00103	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000922	0.00102	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00088	0.00097	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000877	0.000967	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000868	0.000956	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000865	0.000953	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000852	0.000939	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000852	0.000939	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.00085	0.000936	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.00085	0.000936	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000816	0.000899	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000813	0.000896	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000807	0.000889	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000804	0.000886	CbGpPWpGaD
Clidinium—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000755	0.000833	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000751	0.000828	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000749	0.000826	CbGpPWpGaD
Clidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000716	0.000789	CbGpPWpGaD
Clidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000714	0.000786	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000707	0.00078	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000705	0.000777	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000686	0.000756	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000685	0.000755	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000684	0.000754	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000682	0.000752	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.00068	0.00075	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000673	0.000741	CbGpPWpGaD
Clidinium—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000657	0.000724	CbGpPWpGaD
Clidinium—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000655	0.000722	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000633	0.000698	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.000631	0.000695	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000627	0.000691	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—NQO1—Parkinson's disease	0.00062	0.000683	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—TH—Parkinson's disease	0.000611	0.000673	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000598	0.000659	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000597	0.000658	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000596	0.000657	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000595	0.000656	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000595	0.000656	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000593	0.000654	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000586	0.000646	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000586	0.000646	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000584	0.000644	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000575	0.000634	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.000573	0.000632	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000557	0.000614	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000555	0.000612	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.00052	0.000573	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—COMT—Parkinson's disease	0.000519	0.000572	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000518	0.000571	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000517	0.00057	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000516	0.000568	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.00051	0.000562	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000503	0.000555	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000503	0.000555	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000502	0.000553	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000502	0.000553	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000489	0.000539	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000475	0.000524	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000455	0.000501	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000422	0.000465	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000421	0.000464	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.00042	0.000463	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000408	0.00045	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000407	0.000448	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000403	0.000444	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000402	0.000443	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—APOE—Parkinson's disease	0.000391	0.000431	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.00037	0.000408	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000369	0.000407	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000353	0.000389	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000351	0.000387	CbGpPWpGaD
Clidinium—CHRM3—Metabolism—INS—Parkinson's disease	0.000334	0.000368	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000328	0.000361	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000327	0.00036	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.00028	0.000309	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.000279	0.000308	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000208	0.00023	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	0.000208	0.000229	CbGpPWpGaD
Clidinium—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000207	0.000228	CbGpPWpGaD
Clidinium—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	0.000206	0.000228	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000192	0.000211	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	0.000191	0.000211	CbGpPWpGaD
Clidinium—CHRM1—Signaling Pathways—IL6—Parkinson's disease	0.000122	0.000135	CbGpPWpGaD
Clidinium—CHRM3—Signaling Pathways—IL6—Parkinson's disease	0.000122	0.000134	CbGpPWpGaD
